The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor–α inhibitors versus phototherapy: An observational cohort study-Reference-Cited by-同舟云学术

The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor–α inhibitors versus phototherapy: An observational cohort study

Published:2018-07 Issue:1 Volume:79 Page:60-68
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Wu Jashin J.,Sundaram Murali,Cloutier Martin,Gauthier-Loiselle Marjolaine,Guérin Annie,Singh Rakesh,Ganguli Arijit

Publisher

Elsevier BV

Subject

Dermatology

Reference31 articles.

1. Psoriasis: epidemiology, clinical features, and quality of life;Langley;Ann Rheum Dis,2005

2. Quality of life in patients with psoriasis: a systematic literature review;de Korte;J Investig Dermatol Symp Proc,2004

3. Psoriasis causes as much disability as other major medical diseases;Rapp;J Am Acad Dermatol,1999

4. The psychosocial burden of psoriasis;Kimball;Am J Clin Dermatol,2005

5. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities;Ryan;Dermatol Clin,2015

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in Care for Psoriasis;Dermatologic Clinics;2024-07

2. Reducing cardiovascular risk in immune‐mediated inflammatory diseases: Tumour necrosis factor inhibitors compared to conventional therapies—A systematic review and meta‐analysis;Journal of the European Academy of Dermatology and Venereology;2024-03-03

3. Improvement in Cutaneous Conditions Can Benefit Some Health Conditions in the Elderly;Clinical Interventions in Aging;2023-12

4. Risk of stroke in patients with psoriatic disease: a systematic review and meta-analysis;2023-10-27

5. Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease;Frontiers in Immunology;2023-08-15